Literature DB >> 1596000

Dyspnea and leg effort during incremental cycle ergometry.

K J Killian1, E Summers, N L Jones, E J Campbell.   

Abstract

The aim of this study was to establish the perceived magnitude of dyspnea (discomfort associated with breathing) and leg effort experienced by normal subjects during a standardized incremental exercise test to maximal capacity; 460 normal subjects (297 male and 163 female 20 to 70 yr of age) were studied. The perceptual magnitude of both symptoms was rated using simple descriptive phrases (slight, moderate, maximal) tagged to numbers from zero to 10 on the Borg scale, which is an interval scale with ratio properties. Leg effort and dyspnea increased with power output, were higher in women than in men (p less than 0.0001), increased with advancing age (p less than 0.0001), and declined as height increased (p less than 0.0001). Leg effort = 4.82 + 0.007 kpm/min + 1.05 sex + 0.04 age - 0.055 Ht (r = 0.78; SD, 1.80). Dyspnea = 4.96 + 0.006 kpm/min + 0.96 sex + 0.04 age - 0.05 Ht (r = 0.74; SD, 1.80) (m = 1; f = 2). With power output expressed as a percentage of maximal power output (%MPO) both symptoms increased in an alinear manner. Effort = 0.0014 * %MPO1.86 (r = 0.86; SD, 1.50). Dyspnea = 0.0016 * %MPO1.79 (r = 0.81; SD, 1.57). Sex, age, or stature did not contribute to the rating of effort or dyspnea when power output was normalized in this way.

Entities:  

Mesh:

Year:  1992        PMID: 1596000     DOI: 10.1164/ajrccm/145.6.1339

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  20 in total

1.  Effects of an aging pulmonary system on expiratory flow limitation and dyspnoea during exercise in healthy women.

Authors:  Sabrina S Wilkie; Jordan A Guenette; Paolo B Dominelli; A William Sheel
Journal:  Eur J Appl Physiol       Date:  2011-10-05       Impact factor: 3.078

Review 2.  Health status measurement in chronic obstructive pulmonary disease.

Authors:  P W Jones
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

3.  Entia non sunt multiplicanda praeter necessitatem.

Authors:  Marcora Samuele
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

4.  Manipulation of mechanical ventilatory constraint during moderate intensity exercise does not influence dyspnoea in healthy older men and women.

Authors:  Yannick Molgat-Seon; Andrew H Ramsook; Carli M Peters; Michele R Schaeffer; Paolo B Dominelli; Lee M Romer; Jeremy D Road; Jordan A Guenette; A William Sheel
Journal:  J Physiol       Date:  2019-01-18       Impact factor: 5.182

5.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

Review 6.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 7.  Dynamics of the impulse activity of neurons of the neocortex of monkeys in a visual recognition task after brief oxygen deprivation.

Authors:  I S Breslav
Journal:  Neurosci Behav Physiol       Date:  1996 Mar-Apr

Review 8.  Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

Authors:  Bruno-Pierre Dubé; Pierantonio Laveneziana
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 9.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 10.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.